Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BrainCool ABLTS:0G85 72 3-1 Month Momentum % is N/A% as of Sep. 13, 2026. GuruFocus rates LTS:0G85 with a GF Score™ of 72/100 and a GF Value™ of kr2.14. The stock has 7 warning signs investors should review. Among 844 Medical Devices & Instruments companies, BrainCool AB ranks worse than 63.74% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-13), BrainCool AB's 3-1 Month Momentum % is N/A%.
The industry rank for BrainCool AB's 3-1 Month Momentum % or its related term are showing as below:
LTS:0G85's 3-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.815 * Ranked among companies with meaningful 3-1 Month Momentum % only.
BrainCool AB (LTS:0G85) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
BrainCool AB 3-1 Month Momentum % Related Terms
LTS:0G85 vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, BrainCool AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BrainCool AB 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BrainCool AB's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where BrainCool AB's 3-1 Month Momentum % falls into.
BrainCool AB (LTS:0G85) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BrainCool AB (LTS:0G85) has a 3-1 Month Momentum % of N/A% as of Sep. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on BrainCool AB and its competitors. According to the industry distribution chart, BrainCool AB ranks #538 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 63.7%.
Is BrainCool AB's 3-1 Month Momentum % too high?
BrainCool AB's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, BrainCool AB ranks #538 out of 844 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, BrainCool AB has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does BrainCool AB's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BrainCool AB ranks #538 out of 844 companies for 3-1 Month Momentum %. This places BrainCool AB in the lower half of its industry. The industry median 3-1 Month Momentum % is 0.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.82, based on 844 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on BrainCool AB and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BrainCool AB's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrainCool AB stock overvalued right now?
BrainCool AB (LTS:0G85) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is kr2.14, compared to a current price of kr1.54 — trading 28.2% below its estimated fair value. The current 3-1 Month Momentum % is N/A%. BrainCool AB's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For BrainCool AB (LTS:0G85), the current 3-1 Month Momentum % is N/A% as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BrainCool AB (LTS:0G85) Overvalued in 2026?
Based on GuruFocus' analysis, BrainCool AB stock appears to be undervalued.
The current stock price of kr1.54 is trading 28.2% below its estimated GF Value™ of kr2.14.
Key valuation signals for LTS:0G85:
3-1 Month Momentum %: N/A%
GF Value™: kr2.14 vs. price of kr1.54 (28.2% below fair value)
No single metric tells the full story. See the LTS:0G85 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BrainCool AB is a medical device company engaged in developing, marketing, and selling medical cooling systems for diseases like stroke, oral mucositis, migraine, and sudden cardiac arrest.
72GF Score
Get the complete analysis for LTS:0G85
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0G85 has been successfully added to your 
